Azienda Ospedale Policlinico di Bari

Bari 70124

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Melanoma, Primary IgA Nephropathy

Studies at this site

• Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy — Completed
• A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma — Stopped early